Glycaemic control in patients with type 1 diabetes after provision of public hospital-funded insulin pumps

Peter W Goss
Med J Aust 2010; 192 (2): . || doi: 10.5694/j.1326-5377.2010.tb03433.x
Published online: 18 January 2010

To the Editor: Our positive experience with insulin pump therapy (IPT) in children without private health insurance contrasts with that of Thong and colleagues,1 who found that IPT did not significantly reduce glycated haemoglobin (HbA1c) levels in uninsured adults.

  • Peter W Goss

  • Gippsland Paediatrics, Sale, VIC



Comments from Professor Kevin Grumbach and Professor Tom Bodenheimer are gratefully acknowledged.

Competing interests:

Medtronic Australasia provided a grant to research and publish the results of our rural insulin pump program. Medtronic had no input into the content of this letter. I attended Australian Paediatric Society insulin pump workshops in 2008 and 2009 that were sponsored by Medtronic, Animas, Cosmo, Novo Nordisk and Lilly. I have received two Novo Nordisk regional diabetes grants for rural diabetes research.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.